Many patients with chronic lymphocytic leukemia do pretty well with standard treatment. The disease retreats and stays in remission. However, some patients aren’t so fortunate. A new combination may be just what these patients need.

Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.

Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.

Unless a child is involved, age usually isn’t considered when prescribing cancer treatment. A new study finds that might need to be changed for certain leukemia patients.

Two medications are approved in the US to treat advanced melanoma. Zelboraf ( vemurafenib ) was approved in September, 2012. DTIC-Dome ( dacarbazine ) is used to treat Hodgkin's lymphoma as well as melanoma. Which is the better medication?

Cancer in one person can behave very differently than it might in another person. That’s because each person’s genes are unique. So some new cancer treatments can target the individual’s unique genetic fingerprint. Scientists are exploring possible new targets in lymphoma.

There has been a shortage of certain medications for about three years now. Particularly hard hit have been generic injectable drugs. The shortage of one medication has affected kids with cancer.

There has been lots of really good news about a rare blood cancer. Several new drugs have been approved to treat all stages of chronic myeloid leukemia ( CML ). There’s also work happening to go after the disease at deeper levels.

There is excellent news for people with mantle cell lymphoma, a rare blood cancer. An experimental drug is demonstrating impressive results in a phase II clinical trial. But this is a limited research study, and the product is not yet available.

When the World Trade Centers evaporated on 9/11, clouds of toxic chemicals were left in their wake. Researchers wanted to know the impact of these clouds on the health of rescue workers.